A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreading

PloS One
Stephen GottschalkXiao-Tong Song

Abstract

Dendritic cell (DC) vaccines targeting only cancer cells have produced limited antitumor activity in most clinical studies. Targeting cancer-associated fibroblasts (CAFs) in addition to cancer cells may enhance antitumor effects, since CAFs, the central component of the tumor stroma, directly support tumor growth and contribute to the immunosuppressive tumor microenvironment. To co-target CAFs and tumor cells we developed a new compound DC vaccine that encodes an A20-specific shRNA to enhance DC function, and targets fibroblast activation protein (FAP) expressed in CAFs and the tumor antigen tyrosine-related protein (TRP)2 (DC-shA20-FAP-TRP2). DC-shA20-FAP-TRP2 vaccination induced robust FAP- and TRP2-specific T-cell responses, resulting in greater antitumor activity in the B16 melanoma model in comparison to monovalent vaccines or a vaccine encoding antigens and a control shRNA. DC-shA20-FAP-TRP2 vaccination enhanced tumor infiltration of CD8-positive T cells, and induced antigen-spreading resulting in potent antitumor activity. Thus, co-targeting of tumor cells and CAFs results in the induction of broad-based tumor-specific T-cell responses and has the potential to improve current vaccine approaches for cancer.

References

Jun 1, 1971·Transplantation·R J PerperT J Van Gorder
Aug 1, 1994·International Journal of Cancer. Journal International Du Cancer·W J RettigL J Old
Jun 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary L DisisKathy Schiffman
Feb 26, 2004·Nature Medicine·Michael T SpiottoHans Schreiber
Jun 9, 2005·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Thomas Kelly
Jun 24, 2006·The Journal of Clinical Investigation·Markus LoefflerRalph A Reisfeld
Jan 11, 2007·The Journal of Experimental Medicine·Bin ZhangHans Schreiber
Aug 24, 2007·Expert Opinion on Investigational Drugs·Charles Casey Cunningham
Dec 7, 2007·Critical Reviews in Oncology/hematology·Alessio NencioniPeter Brossart
Jun 21, 2008·The New England Journal of Medicine·Naomi N HunderCassian Yee
Dec 5, 2008·Trends in Genetics : TIG·Kornelia PolyakIan G Campbell
Feb 13, 2009·Current Opinion in Genetics & Development·Arne Ostman, Martin Augsten
Feb 13, 2009·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·G Chometon, V Jendrossek
Nov 19, 2009·The Journal of Clinical Investigation·Angélica M SantosEllen Puré
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John H SampsonDarell D Bigner
Apr 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Roya NavabMing-Sound Tsao
Oct 15, 2011·Gut·Silvio DaneseStefania Vetrano
Jun 23, 2012·Cancer Immunology, Immunotherapy : CII·Lotte Engell-NoerregaardInge Marie Svane
Dec 1, 2012·Immunotherapy·Sunitha KakarlaStephen Gottschalk

❮ Previous
Next ❯

Citations

Jan 23, 2016·Stem Cells International·Francesca Cammarota, Mikko O Laukkanen
Feb 15, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Yali HanYuping Sun
Mar 5, 2017·Seminars in Cancer Biology·Mohanraj RamachandranMagnus Essand
Nov 23, 2018·Cancer Metastasis Reviews·J M Houthuijzen, J Jonkers
Oct 24, 2019·Journal of Cellular and Molecular Medicine·Yuanyuan AnQing Yang
Apr 30, 2017·Cancer Immunology, Immunotherapy : CII·Hong JiangDavid G DeNardo
Apr 14, 2018·Nature Reviews. Clinical Oncology·Kenneth C ValkenburgKenneth J Pienta
Feb 13, 2014·Oncotarget·Cleo GoyvaertsKarine Breckpot
Jul 1, 2020·Cancer Metastasis Reviews·Allison A Fitzgerald, Louis M Weiner
Dec 23, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elizabeth K DuperretDavid B Weiner
May 10, 2020·Seminars in Radiation Oncology·Arta M MonjazebKristina Young
Apr 11, 2019·Bioconjugate Chemistry·Hallie M HintzAaron M LeBeau

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
transgenic

Software Mentioned

CellQuest
Elispot
KS Elispot

Related Concepts

Related Feeds

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.